Racial disparities in chemotherapy administration for early-stage breast cancer: a systematic review and meta-analysis
- 65 Downloads
We conducted a systematic review and meta-analysis to measure the extent to which race is associated with delayed initiation or receipt of inadequate chemotherapy among women with early-stage breast cancer.
We performed a systematic search of all articles published from January 1987 until June 2017 within four databases: PubMed/Medline, EMBASE, CINAHL, and Cochrane CENTRAL. Eligible studies were US-based and examined the influence of race on chemotherapy delays, cessation, or dose reductions among women with stage I, II, or III breast cancer. Data were pooled using a random effects model.
A total of twelve studies were included in the quantitative analysis. Blacks were significantly more likely than whites to have delays to initiation of adjuvant therapy of 90 days or more (OR 1.41, 95% CI 1.06–1.87; X² = 31.05, p < 0.00001; I² = 90%). There was no significant association between race and chemotherapy dosing. Due to overlap between studies assessing the relationship between race and completion of chemotherapy, we conducted two separate analyses. Black patients were significantly more likely to discontinue chemotherapy, however, this was no longer statistically significant when larger numbers of patients with more advanced (stage III) breast cancer were included.
These results suggest that black breast cancer patients experience clinically relevant delays in the initiation of adjuvant chemotherapy more often than white patients, which may in part explain the increased mortality observed among black patients.
KeywordsRace Disparities Chemotherapy administration Delays Relative dose intensity
Nina A. Bickell MD MPH, Dawn L. Hershman MD MS, and Joseph Unger, PhD MS for provision of data used in the meta-analysis.
Compliance with ethical standards
Conflict of interest
All authors declared that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
- 22.Simon MS, Lamerato L, Krajenta R et al (2012) Racial differences in the use of adjuvant chemotherapy for breast cancer in a large urban integrated health system. Int J Br cancer 2012:453985Google Scholar
- 32.Yi M, Mittendorf EA, Cormier JN et al (2011) Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system. J Clin Oncol 29(35):4654–4661CrossRefPubMedPubMedCentralGoogle Scholar